Stigmasterol elicits antiviral activity against influenza viruses through virucidal and entry inhibition activity in vitro
{{output}}
Influenza viruses pose a significant global public health threat, leading to recurrent seasonal epidemics and occasional pandemics. The rising prevalence of drug-resistant strains highlights the urgent need for new antiviral agents with alternative mechanisms ... ...
